Department of Neurology, Haukeland University Hospital, University of Bergen, Bergen, Norway.
Acta Neurol Scand. 2010 Dec;122(6):414-7. doi: 10.1111/j.1600-0404.2010.01331.x.
High body temperature may promote clot lysis whereas low body temperature is neuroprotective in patients with cerebral infarction. We hypothesized that high body temperature is associated with favorable outcome in patients treated with tissue plasminogen activator (tPA) and that low body temperature is associated with favorable outcome in patients not treated with tPA.
Patients (n = 111) who were treated with tPA and patients (n = 139) who were not treated with tPA, but presented within 6 h of stroke onset were included. Patients with no temperature measurements within 6 h of stroke onset were excluded. National Institute of Health Stroke Scale (NIHSS) score was obtained on admission. Modified Rankin score (mRS) was obtained after 1 week. Favorable outcome was defined as mRS 0-2 and unfavorable outcome as mRS 3-6.
On logistic regression analysis, high body temperature was independently associated with favorable outcome among patients treated with tPA (OR = 3.7, P = 0.009) and low body temperature was independently associated with favorable prognosis among patients not treated with tPA (OR = 2.0, P = 0.042).
Our study suggests that the effect of high body temperature on clot lysis is more important than the neuroprotective effect of low body temperature in the early phase after cerebral infarction treated with tPA.
高热可能促进血栓溶解,而低温在脑梗死患者中具有神经保护作用。我们假设,高热与接受组织型纤溶酶原激活剂(tPA)治疗的患者的良好预后相关,而低温与未接受 tPA 治疗的患者的良好预后相关。
纳入了接受 tPA 治疗的患者(n=111)和未接受 tPA 治疗但在卒中发作后 6 小时内就诊的患者(n=139)。排除了卒中发作后 6 小时内无体温测量的患者。入院时采用国立卫生研究院卒中量表(NIHSS)评分,第 1 周采用改良 Rankin 量表(mRS)评分。良好预后定义为 mRS 0-2,不良预后定义为 mRS 3-6。
在 logistic 回归分析中,高热与接受 tPA 治疗的患者的良好预后独立相关(OR=3.7,P=0.009),低温与未接受 tPA 治疗的患者的良好预后独立相关(OR=2.0,P=0.042)。
我们的研究表明,在接受 tPA 治疗后的早期,高热对血栓溶解的影响比低温的神经保护作用更重要。